BCAL Diagnostics Limited is a biotechnology and medical devices company, focused on developing and commercialising innovative diagnostic technologies. The company's operations include the development, manufacture and sale of diagnostic tests and instruments, as well as research and development activities. BCAL's current projects are centred around the development of a point-of-care diagnostic platform for the early detection of cancer, as well as a range of molecular diagnostic tests. The company's core objective is to improve the accuracy and speed of cancer diagnosis and treatment.